Stockreport

Relay Therapeutics to Participate in Two Upcoming Investor Conferences in March

Relay Therapeutics, Inc.  (RLAY) 
PDF CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing pot [Read more]